Skip to search formSkip to main contentSkip to account menu

5-BrQNT

Known as: 3-quinuclidinyl 2-(5-bromothienyl)-2-thienylglycolate 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

GlycolatesQuinuclidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
In vivo competition studies of Z-(-,-)-[125I]IQNP against 3-quinuclidinyl 2-(5-bromothienyl)-2-thienylglycolate (BrQNT) demonstrating in vivo m2 muscarinic subtype selectivity for BrQNT
Alzheimer’s disease (AD) involves selective loss of muscarinic m2, but not m1, subtype neuroreceptors in cortical and hippocampal… 
1997
1997
Molecular modeling of the interaction of diagnostic radiopharmaceuticals with receptor proteins: m2 antagonist binding to the muscarinic m2 subtype receptor.
Models of the m2 muscarinic receptor have been built and acetylcholine and an antagonist of the quinuclidinyl benzilate family… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)